Toxicity and Efficacy of Daily Dapsone as Pneumocystis jiroveci Prophylaxis after Hematopoietic Stem Cell Transplantation: A Case-Control Study

This publication has 14 references indexed in Scilit:

• Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: Recommendations of Centers for Disease Control, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation
  Transplantation and Cellular Therapy, 2000
• High Rates of Pneumocystis carinii Pneumonia in Allogeneic Blood and Marrow Transplant Recipients Receiving Dapsone Prophylaxis
  Clinical Infectious Diseases, 1999
• Atovaquone Compared with Dapsone for the Prevention ofPneumocystis cariniiPneumonia in Patients with HIV Infection Who Cannot Tolerate Trimethoprim, Sulfonamides, or Both
  New England Journal of Medicine, 1998
• Dapsone for Pneumocystis carinii prophylaxis in children undergoing bone marrow transplantation
  Bone Marrow Transplantation, 1997
• Risks and benefits of aerosolized pentamidine and cotrimoxazole in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: a two-year Italian multicentric randomized controlled trial
  Journal of Infection, 1996
• A Randomized Trial of Three Antipneumocystis Agents in Patients with Advanced Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1995
• Primary prophylaxis for Pneumocystis carinii pneumonia
  AIDS, 1993
• A Controlled Trial of Trimethoprim–Sulfamethoxazole or Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis carinii Pneumonia in Patients with the Acquired Immunodeficiency Syndrome
  New England Journal of Medicine, 1992
• A Controlled Trial of Aerosolized Pentamidine or Trimethoprim–Sulfamethoxazole as Primary Prophylaxis againstPneumocystis cariniiPneumonia in Patients with Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1992
• Pulmonary Complications of Bone Marrow Transplantation
  Chest, 1985